Mabwell’s IND application for 9MW5211 to treat inflammatory bowel disease receives US FDA clearance to begin clinical studies

Join Pharma | Login

	Editorial


	A FLAWED DECISION
	Wednesday, May 6, 2026
	The Union Health Ministry has recently amended the recruitment rules for appointment of Drugs Controller General of India (DCGI) and has revised the eligibility and qualification criteria. The new recruitment rules
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	Mabwell’s IND application for 9MW5211 to treat inflammatory bowel disease receives US FDA clearance to begin clinical studies
17:40 [IST]	Abbott introduces device to repair tricuspid valve leakage through minimal invasive treatment
17:00 [IST]	US FDA grants approval to Partner Therapeutics’ Bizengri to treat NRG1 fusion-positive cholangiocarcinoma under the National Priority Voucher Pilot Programme
16:00 [IST]	Caris Life Sciences submits application to NYSDOH Clinical Laboratory Evaluation Programme for Caris Assure blood based testing authorization
15:00 [IST]	European Commission approves Bristol Myers Squibb’s Sotyktu for the treatment of active psoriatic arthritis in adults
14:50 [IST]	L V Prasad Eye Institute’s 8th edition ‘WHITATHON Run’ to raise funds for retinoblastoma treatment

more news >>

TOP NEWS


08:00 [IST]	Panel asks Ministry of Ayush to identify priority partner countries for promotion of traditional medicines
08:00 [IST]	Manufacturers await NPPA intervention as production of cancer drugs become unviable due to platinum price surge
08:00 [IST]	Indian Pharmacist Association opposes new recruitment rules for DCGI
08:00 [IST]	BDCDA concerned over growing threat of drug misuse and antimicrobial resistance
08:00 [IST]	PCI directs colleges to implement Aadhar enabled attendance for all M.Pharm students
08:00 [IST]	Parliamentary Panel asks Ministry of Ayush to create dedicated Ayush Infra Fund

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Nona Biosciences appoints Dr Josh Xiao as chief scientific officer to advance global scientific strategy and innovation
17:00 [IST]	Plus Therapeutics’ wholly owned subsidiary, CNSide Diagnostics receives Medicare enrollment approval
16:00 [IST]	Hongene Biotech shows advanced oligonucleotide CDMO capabilities via support of SiranBio’s dual-target siRNA programme
15:00 [IST]	Altasciences and Certara ink strategic partnership to accelerate early drug development
14:00 [IST]	NIH-funded research shows oral small-molecule GLP-1 drugs penetrate deep into the brain to suppress cravings
13:00 [IST]	RIVANNA receives US FDA 510(k) clearance for its Accuro XV musculoskeletal ultrasound imaging system

more news >>

INTERVIEW


Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana

Past Interviews...

	What's New?

Biocon net profit declines 63.4% in Q4 FY26 Indoco Remedies net loss narrows during Q4, FY26 Emcure Pharma net profit up 23.6% in Q4 FY26 Syngene PAT before exceptional items slips in Q3 by 16%, revenue up 2% to Rs. 1,037 crore cap dianazole 100 mg

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers